Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia

Genes Chromosomes and Cancer

Volumn 29, Issue 4, 2000, Pages 371-377

  Watt, Paul M ^a   Kumar, Rolee ^a   Kees, Ursula R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA; METHYLATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; SEQUENCE ANALYSIS; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA; LEUKEMIA, T-CELL, ACUTE; MODELS, GENETIC; ONCOGENE PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES;

EID: 0033758181     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y     Document Type: Article

References (42)

1. Antequera F, Bird A. 1999. CpG islands as genomic footprints of promoters that are associated with replication origins. Curr Biol 9:661-667.
2. Asimakopoulos F, Shteper P, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y, Ben-Yehuda D. 1999. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood 94:2452-2460.
3. Ausubel F, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1989. Current protocols in molecular biology. New York: Greene Publishing Associates/Wiley Intersciences.
4. Borrello MG, Pierotti MA, Bongarzone I, Donghi R, Mondellini P, Della Porta G. 1987. DNA methylation affecting the transforming activity of the human Ha-ras oncogene. Cancer Res 47:75-79.
5. Borrello MG, Pierotti MA, Tamborini E, Biassoni D, Rizzetti MG, Pilotti S, Della Porta G. 1992. DNA methylation of coding and non-coding regions of the human H-RAS gene in normal and tumor tissues. Oncogene 7:269-275.
6. Boyes J, Bird A. 1991. DNA methylation inhibits transcription indirectly via a methyl -CpG binding protein. Cell 64:1123-1134.
7. Brake R, Kees UR, Watt P. 1998. Multiple negative elements contribute to repression of the HOX11 proto-oncogene. Oncogene 17:1787-1795.
8. Cameron D, Bachman K, Muyohanen S, Herman J, Baylin H. 1999. Synergy of demethylation and hisone deacetylase inhibition in the re-expression of genes silenced in a cancer. Nat Genet 21: 103-107.
9. Chen Z, Pikaard C. 1997. Epigenetic silencing of RNA polymerase 1 transcription: a role for DNA methylation and histone modification in nucleolar dominance. Genes Dev 11:2124-2136.
10. Clark S, Harison J, Paul C, Frommer M. 1994. High sensitivity mapping of methylated cytosines. Nucl Acids Res 22:2990-2997.
11. Counts JL, Goodman JI. 1994. Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol Carcinog 11:185-188.
12. Counts JL, Goodman JI. 1995. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13-15.
13. Dubé IE, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi S, Crist WM, Carroll AJ, Minowada J, Baker JB. 1991. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10; 14). Blood 78:2996-3003.
14. Ferguson A, Lapidus R, Davidson N. 1998. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression. Oncogene 17:577-583.
15. Fitzpatrick D, Shirley K, MacDonald L, Bielefeldt-Ohmann H, Kay G, Kelso A. 1998. Distinct methylation of the interferon-g (IFN-g) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-g promoter demethylation and mRNA expression are heritably in CD44 highCD8+ T cells. J Exp Med 188:103-117.
16. Fitzpatrick D, Shirley K, Kelso A. 1999. Cutting edge: stable epigenetic inheritance of regional IFN-g promoter demethylation in CD44high /CD8+ T lymphocytes. J Immunol 162:5053-5057.
17. Frommer M, McDonald L, Millar D, Collis C, Watt F, Grigg G, Malloy P, Paul C. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827-1831.
18. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. 2000. Methylation patterns of the E-cadherin. 5′ GpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275:2727-2732
19. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. 1995. Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530.
20. Ivy WN, Ng MH L, Lee JCK, Lo KW, Chung YK, Huang DP. 1999. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br J Haematol 103:168-175.
21. Jones P, Taylor S. 1980. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20:85-93.
22. Kagan J, Finger LR, Letofsky J, Finan J, Nowell PC, Croce CM. 1989. Clustering of breakpoints on chromosome 10 in acute T-cell leukemias with the t(10:14) chromosomal translocation. Proc Natl Acad Sci USA 86:4161-4165.
23. Kagan J, Joe Y, Freireich EJ. 1994. Joining of recombination signals on the der 14q-chromosome in T-cell acute leukemia with t(10; 14) chromosome translocation. Cancer Res 54:226-230.
24. Kees UR, Ford J, Price PJ, Meyer BF, Herrmann RP. 1987. PER-117: a new human ALL cell line with an immature thymic phenotype. Leuk Res 11:489-498.
25. Kees UR, Lukeis R, Ford J, Garson OM. 1989. Establishment and characterization of a childhood T-cell acute lymphoblastic leukemia cell line. PER-255, with chromosome abnormalities involving 7q32-34 in association with T-cell receptor-beta gene rearrangement. Blood 74:369-373.
26. Kennedy MA, Gonzalez SR, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH. 1991. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci USA 88:8900-8904.
27. Klempnauer KH. 1993. Methylation-sensitive DNA binding by v-myb and c-myb proteins. Oncogene 8:111-115.
28. Matsuo K, Kilke J, Georgiev O, Merti P, Giovanninni N, Runger D. 1998. An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA. EMBO J 17:1446-1453.
29. McDonald L, Kay G. 1997. Methylation analysis using bisulfite sequencing: application to small numbers of intact cells. Biotechniques 22:272-274.
30. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692.
31. Munnes M, Patrone G, Schmitz B, Romeo G, Doerfler W. 1998. A 5′-CG-3′-rich region in the promoter of the transcriptionally frequently silenced RET proto-oncogene lacks methylated cytidine residues. Oncogene 17:2573-2583.
32. Nakamura M, Sugita K, Inukai T, Goi K, Lijima K, Tezuka T, Kojika S, Shiraishi K, Miyamoto N, Karakida N, Kagami K, Okoyama T, Mori T, Nakazawa S. 1999. p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation. Leukemia 13: 884-890.
33. Rein T, Natale DA, Gärtner U, Niggemann M, DePamphilis ML, Zorbas H. 1997. Absence of an unusual "densely methylated island" at the hamster dhfr ori-beta. J Biol Chem 272:10021-10029.
34. Salvati PD, Ranford PR, Ford J, Kees UR. 1995. HOX11 expression in pediatric lymphoblastic leukemia is associated with T-cell phenotypc. Oncogene 11:133-138.
35. Shmookler Reis RJ, Finn GK, Smith K, Goldstein S. 1990. Clonal variation in gene methylation: c-H-ras and alpha-hCG regions vary independently in human fibroblast lineages. Mutat Res 237: 45-57.
36. Tazi J, Bird A. 1990. Alternative chromatin structure at CpG islands. Cell 60:909-920.
37. Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T, Nagao M. 1997. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo-and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci USA 94:2284-1189.
38. Vorce RL, Goodman JI. 1989a. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors. Toxicol Appl Pharmacol 100:398-410.
39. Vorce RL, Goodman JI. 1989b. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Mol Toxicol 2:99-116.
40. Watt P, Ranford P, Kees UR. 1999. Sequence of 10q24 locus surrounding the HOX11 oncogene reveals a new gene HUG1 expressed in a T-ALL cell line. Gene 234:169-176.
41. Wolffe A, Jones P, Wade P. 1999. DNA demethylation. Proc Natl Acad Sci USA 96:5894-5896.
42. Wu H, Minden M. 1997. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl. Biochem Biophys Res Commun 234: 742-747.